Record-Breaking Ebola Trial: Two Drugs Tested as DRC Outbreak Expands
Just six weeks after the international health emergency declaration for the Bundibugyo Ebola strain, an unprecedented clinical trial began in Bunia, DRC, testing remdesivir and MBP134. With over 1,792 confirmed cases and 625 deaths as of July 9, 2026, the scientific community aims to reduce the mortality of a virus that kills one in three infected and has no approved vaccine or treatment.









